Detalhe da pesquisa
1.
Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients.
Clin Immunol
; 259: 109901, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218209
2.
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Lancet
; 401(10373): 281-293, 2023 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36566761
3.
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
Clin Infect Dis
; 77(7): 950-960, 2023 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37338118
4.
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.
Br J Haematol
; 202(3): 498-503, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37303189
5.
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients.
J Clin Immunol
; 43(6): 1083-1092, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148422
6.
The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease.
Ann Clin Microbiol Antimicrob
; 22(1): 14, 2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800956
7.
Airway inflammation and dysbiosis in antibody deficiency despite the presence of IgG.
J Allergy Clin Immunol
; 149(6): 2105-2115.e10, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34968528
8.
Treatment of chronic or relapsing COVID-19 in immunodeficiency.
J Allergy Clin Immunol
; 149(2): 557-561.e1, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780850
9.
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
PLoS Med
; 19(10): e1004120, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260627
10.
Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies.
Clin Immunol
; 236: 108938, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121105
11.
The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder.
J Clin Immunol
; 42(2): 312-324, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731398
12.
Predictive Factors for and Complications of Bronchiectasis in Common Variable Immunodeficiency Disorders.
J Clin Immunol
; 42(3): 572-581, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015197
13.
Bowel Histology of CVID Patients Reveals Distinct Patterns of Mucosal Inflammation.
J Clin Immunol
; 42(1): 46-59, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599484
14.
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.
J Clin Immunol
; 42(5): 923-934, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35420363
15.
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK.
Clin Exp Immunol
; 209(3): 247-258, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641155
16.
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials.
Br J Clin Pharmacol
; 88(12): 5428-5433, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040430
17.
Early phase dose-finding trials in virology.
Stat Med
; 40(2): 240-253, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053601
18.
RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature.
J Inherit Metab Dis
; 43(5): 1002-1013, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32187699
19.
Viral infection in primary antibody deficiency syndromes.
Rev Med Virol
; 29(4): e2049, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016825
20.
Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products.
J Infect Dis
; 219(2): 245-253, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30137432